Vasten and hepatocellular damage Patient Reports February 13, 2012
Vasten Side Effects Report #5443083-2
Vasten side effect was reported by a Health Professional from FRANCE on Aug 29, 2007. Male patient, 66 years of age, was diagnosed with hypercholesterolaemia, ischaemic heart disease prophylaxis, myocardial infarction, atrial fibrillation
and was treated with Vasten. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, cytolytic hepatitis, fibrin increased, hepatocellular damage, myalgia. Vasten dosage: unknown. During the same period patient was treated with CELIPROLOL, LASIX, PREVISCAN, LISINOPRIL. Patient was hospitalized. Patient recovered.Vasten Side Effects Report #5099937-2
Vasten side effect was reported by a Pharmacist from FRANCE on Apr 21, 2006. Male patient, 55 years of age, was diagnosed with hypercholesterolaemia, diabetes mellitus and was treated with Vasten. After drug was administered, patient experienced the following side effects: hepatocellular damage, hypoglycaemia. Vasten dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, PERINDOPRIL ERBUMINE, VERAPAMIL, CLOPIDOGREL BISULPHATE. Patient recovered.
Vasten Side Effects Report #4837250-6
Vasten side effect was reported by a Health Professional from FRANCE on Nov 16, 2005. Female patient, 86 years of age, was treated with Vasten. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, hepatitis
, hepatocellular damage, hyperbilirubinaemia, vomiting. Vasten dosage: unknown. During the same period patient was treated with GARDENAL, DIAMICRON, URBANYL, DIFFU, ARICEPT, PLATELET AGGREGATION INHIBITOR. Patient was hospitalized. Patient recovered.Vasten Side Effects Report #4879675-9
Vasten side effect was reported by a Health Professional from FRANCE on Nov 16, 2005. Female patient, 86 years of age, was treated with Vasten. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, hepatocellular damage, hyperbilirubinaemia, vomiting. Vasten dosage: unknown. During the same period patient was treated with GARDENAL, DIAMICRON, URBANYL, DIFFU, ARICEPT, PLATELET AGGREGATION INHIBITOR. Patient was hospitalized. Patient recovered.
Vasten and hepatocellular damage 